BAJAJ BROKING

Notification close image
No new Notification messages
card image
Amanta Healthcare Ltd IPO
Apply for the Amanta Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

543520

GLHRL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Global Longlife Hospital and R Share Price Update

As of the latest trading session, Global Longlife Hospital and R share price is currently at ₹ 26.4, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 26.40 and ₹ 26.40. Over the past year, Global Longlife Hospital and R has achieved a return of -26.56 %. In the last month alone, the return has been 19.99 %. Read More...

Investment Returns

Over 1 Month 19.99% Over 3 Months -10.50% Over 6 Months 19.40% Over 1 Year -26.56%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Global Longlife Hospital and R fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    27.70

  • P/E Ratio (TTM)

    138.95

  • Beta

    -0.34

  • Book Value / share

    25.51

  • Return on equity

    -17.04%

  • EPS (TTM)

    0.00

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    1.07

info icon alternate text

Global Longlife Hospital and R Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2023 (Values in Cr)
Revenue 11.70
Operating Expense 10.22
Net Profit 1.07
Net Profit Margin (%) 9.14
Earnings Per Share (EPS) 1.05
EBITDA 2.42
Effective Tax Rate (%) 34.75
Particulars SEP 2022 (Values in Cr)
Revenue 11.80
Operating Expense 10.79
Net Profit 0.76
Net Profit Margin (%) 6.44
Earnings Per Share (EPS) 0.74
EBITDA 1.83
Effective Tax Rate (%) 29.24
Particulars MAR 2025 (Values in Cr)
Revenue 0.58
Operating Expense 5.50
Net Profit 0.20
Net Profit Margin (%) 34.48
Earnings Per Share (EPS) 0.19
EBITDA 0.86
Effective Tax Rate (%) -100.00
Particulars MAR 2024 (Values in Cr)
Revenue 13.51
Operating Expense 15.85
Net Profit -2.19
Net Profit Margin (%) -16.21
Earnings Per Share (EPS) -2.08
EBITDA -0.25
Effective Tax Rate (%) 3.52
Particulars MAR 2023 (Values in Cr)
Revenue 23.50
Operating Expense 21.02
Net Profit 1.83
Net Profit Margin (%) 7.78
Earnings Per Share (EPS) 1.79
EBITDA 4.27
Effective Tax Rate (%) 32.47
Particulars MAR 2022 (Values in Cr)
Revenue 32.82
Operating Expense 27.33
Net Profit 3.57
Net Profit Margin (%) 10.87
Earnings Per Share (EPS) 5.11
EBITDA 8.25
Effective Tax Rate (%) 37.47
Particulars MAR 2021 (Values in Cr)
Revenue 32.70
Operating Expense 31.00
Net Profit 2.05
Net Profit Margin (%) 6.26
Earnings Per Share (EPS) 2.92
EBITDA 5.50
Effective Tax Rate (%) -16.47
Particulars MAR 2025 (Values in Cr)
Book Value / Share 25.51
ROE % -17.04
ROCE % -13.27
Total Debt to Total Equity 0.24
EBITDA Margin -689.66
Particulars MAR 2024 (Values in Cr)
Book Value / Share 24.70
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.24
EBITDA Margin -1.63
Particulars MAR 2023 (Values in Cr)
Book Value / Share 61.23
ROE % 4.50
ROCE % 6.33
Total Debt to Total Equity 0.22
EBITDA Margin 18.38
Particulars MAR 2022 (Values in Cr)
Book Value / Share 24.23
ROE % 23.30
ROCE % 25.65
Total Debt to Total Equity 0.84
EBITDA Margin 25.81
Particulars MAR 2021 (Values in Cr)
Book Value / Share 19.54
ROE % 16.29
ROCE % 12.64
Total Debt to Total Equity 1.61
EBITDA Margin 16.82
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 21.49
Total Assets 26.84
Total Liabilities 26.84
Total Equity 26.78
Share Outstanding 10500000
Price to Book Ratio 0.74
Return on Assets (%) 0.74
Return on Capital (%) 0.74
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.38
Total Assets 41.73
Total Liabilities 41.73
Total Equity 25.93
Share Outstanding 10500000
Price to Book Ratio 1.58
Return on Assets (%) -5.24
Return on Capital (%) -5.66
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.60
Total Assets 75.93
Total Liabilities 75.93
Total Equity 64.28
Share Outstanding 10500000
Price to Book Ratio 0.73
Return on Assets (%) 2.40
Return on Capital (%) 2.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.21
Total Assets 33.97
Total Liabilities 33.97
Total Equity 16.96
Share Outstanding 7000000
Price to Book Ratio 0.00
Return on Assets (%) 10.51
Return on Capital (%) 13.93
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.43
Total Assets 36.77
Total Liabilities 36.77
Total Equity 13.67
Share Outstanding 7000000
Price to Book Ratio 0.00
Return on Assets (%) 5.56
Return on Capital (%) 6.66
Particulars MAR 2025 (Values in Cr)
Net Income 0.09
Cash from Operations 12.58
Cash from Investing 21.79
Cash from Financing -13.01
Net change in Cash 21.10
Free Cash Flow 12.65
Particulars MAR 2024 (Values in Cr)
Net Income -2.26
Cash from Operations -4.97
Cash from Investing -0.81
Cash from Financing 2.67
Net change in Cash -3.21
Free Cash Flow -3.92
Particulars MAR 2023 (Values in Cr)
Net Income 2.70
Cash from Operations -39.14
Cash from Investing -1.90
Cash from Financing 45.69
Net change in Cash 3.38
Free Cash Flow -37.14
Particulars MAR 2022 (Values in Cr)
Net Income 5.71
Cash from Operations 8.75
Cash from Investing 0.01
Cash from Financing -9.65
Net change in Cash -0.22
Free Cash Flow 9.23
Particulars MAR 2021 (Values in Cr)
Net Income 1.75
Cash from Operations 6.87
Cash from Investing 0.01
Cash from Financing -7.22
Net change in Cash -0.32
Free Cash Flow 6.91
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7676.95 70.15 13.45 110382.76 6002.15 / 7981.20
FORTIS MALAR HOSPITALS LIMITED 67.36 27.38 4.18 126.24 51.01 / 98.70
SHREE PACETRONIX LTD. 167.30 57.69 4.36 60.22 61.11 / 187.00
TRANSGENE BIOTEK LTD. 3.99 0.00 3.01 30.23 3.22 / 8.88
VIMTA LABS LIMITED 656.00 48.02 8.51 2919.57 254.43 / 728.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7676.95 81.68 12.63 110382.76 6002.15 / 7981.20
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 37.98 0.00 -15.01 28.37 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 6299.05 31.26 6.34 6891.16 4777.15 / 6525.00

Global Longlife Hospital and R Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
26.40 4.97 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 24.70
  • 26 Days 24.00
  • 10 Days 24.00
  • 50 Days 24.70
  • 12 Days 23.90
  • 100 Days 26.00
  • 20 Days 23.90
  • 200 Days 28.80
26.40 PIVOT

First Support

26.40

First Resistance

26.40

Second Support

26.40

Second Resistance

26.40

Third Support

26.40

Third Resistance

26.40

RSI

59.44

ADX

15.88

MACD

-0.14

Williams % R

0.00

Commodity Channel Index (CCI)

174.17

Date

2025-09-01

Week

4667.00

Same Day

5000.00

Month

3182.00

1 Year

-0.35

3 Year

-0.17

Over 1 Month

19.99%

down

Over 1 Year

-26.56%

down

Over 3 Months

-10.50%

down

Over 3 Years

-30.33%

down

Over 6 Months

19.40%

down

Over 5 Years

0.00%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

Global Longlife Hospital and R shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

Global Longlife Hospital and R corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Global Longlife Hospital and R Share Price

Global Longlife Hospital and Research Limited was originally incorporated as 'Global Longlife Hospital and Research Private Limited' on January 20, 2012 with Registrar of Companies, Gujarat. Subsequently, Company was converted into a Public Limited Company and , name of the Company was changed to 'Global Longlife Hospital and Research Limited' vide fresh Certificate of Incorporation dated August 31, 2021.

The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in March 2012. The Hospital started journey in 2015 & determined to build an institution that offer to every human being, high quality healthcare at affordable prices in Ahmedabad.
Mr. Dhruv Jani had also joined the hospital business with his father in July 2015. The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017. At present the Promoters along with his family members hold 81.43 % stake in the Company.

The Company came up with an Initial Public Offer by 35,00,000 Equity Shares of Rs. 10/- each, aggregating to Rs. 49 Crore in April, 2022.

The Company is a Multi Speciality Tertiary Care Hospital of Gujarat with 110 beds well equipped for Medical & Surgical Specialities. Company provide platform to the doctors for treatment of their patients. Apart from the 11 full time consultants, the Hospital has a team of more than 30 experienced doctors as a consultant to serve patients. Its staff strength comprises 37 nursing staff and more than 50 paramedical, corporate and support staff and pharmacists.

The Hospital provide comprehensive healthcare services across a range of specialties and super-specialties. These include Cardiology, Allergy and immunology, oncology, Diabetes & Endocrinology, Anesthesiology, Pain Management, Internal Medicine , Nephrology, Neurology, Dermatology, plastic Surgery and others.

Parent organization Indian Private
NSE symbol [-]
Founded 2012
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Global Longlife Hospital and Research Ltd?

Answer Field

Global Longlife Hospital and Research Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 26.40 as on Sep 01 2025 12:00 AM.

What is the Market Cap of Global Longlife Hospital and Research Ltd Share?

Answer Field

The market cap of Global Longlife Hospital and Research Ltd for NSE ₹ 0.00 & for BSE ₹ 27.70 as on Sep 01 2025 12:00 AM.

What is the 52 Week High and Low of Global Longlife Hospital and Research Ltd?

Answer Field

The 52 Week High and Low of Global Longlife Hospital and Research Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 46.44 and ₹ 18.30.

What is 1 year return for Global Longlife Hospital and Research Ltd?

Answer Field

The 1 year returns on the stock has been -26.56%.

What is the P/E Ratio of Global Longlife Hospital and Research Ltd Share?

Answer Field

As on Sep 01 2025 12:00 AM the price-to-earnings (PE) ratio for Global Longlife Hospital and Research Ltd share is 138.95.

What is the PB ratio of Global Longlife Hospital and Research Ltd Share?

Answer Field

As on Sep 01 2025 12:00 AM, the price-to-book (PB) ratio for Global Longlife Hospital and Research Ltd share is 25.51.

How to Buy Global Longlife Hospital and Research Ltd Share?

Answer Field

You can trade in Global Longlife Hospital and Research Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Global Longlife Hospital and Research Ltd Share on Bajaj Broking App?

Answer Field

To buy Global Longlife Hospital and Research Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Global Longlife Hospital and Research Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91